GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $352,000 | -7.9% | 8,075 | -6.9% | 0.05% | -3.8% |
Q4 2021 | $382,000 | +15.4% | 8,670 | +0.1% | 0.05% | +8.3% |
Q3 2021 | $331,000 | -4.1% | 8,664 | +0.0% | 0.05% | -4.0% |
Q2 2021 | $345,000 | +11.7% | 8,660 | +0.1% | 0.05% | +4.2% |
Q1 2021 | $309,000 | -4.9% | 8,655 | -1.9% | 0.05% | -20.0% |
Q4 2020 | $325,000 | +1.2% | 8,825 | +3.6% | 0.06% | -15.5% |
Q3 2020 | $321,000 | -7.5% | 8,522 | +0.0% | 0.07% | -11.2% |
Q2 2020 | $347,000 | +5.8% | 8,518 | -1.7% | 0.08% | -11.1% |
Q1 2020 | $328,000 | -15.5% | 8,667 | +4.9% | 0.09% | +7.1% |
Q4 2019 | $388,000 | +13.1% | 8,259 | +2.8% | 0.08% | +5.0% |
Q3 2019 | $343,000 | +8.2% | 8,031 | +1.3% | 0.08% | +35.6% |
Q2 2019 | $317,000 | -7.6% | 7,927 | -3.3% | 0.06% | +1.7% |
Q1 2019 | $343,000 | -10.2% | 8,200 | -18.1% | 0.06% | -20.5% |
Q4 2018 | $382,000 | -17.5% | 10,008 | -13.1% | 0.07% | -2.7% |
Q3 2018 | $463,000 | -3.7% | 11,518 | -3.4% | 0.08% | -12.8% |
Q2 2018 | $481,000 | -1.6% | 11,919 | -4.8% | 0.09% | -9.5% |
Q1 2018 | $489,000 | +48.2% | 12,521 | +34.7% | 0.10% | +72.7% |
Q4 2017 | $330,000 | -32.0% | 9,297 | -22.1% | 0.06% | -36.0% |
Q3 2017 | $485,000 | -5.8% | 11,931 | -0.1% | 0.09% | -6.5% |
Q2 2017 | $515,000 | -1.0% | 11,941 | -3.2% | 0.09% | 0.0% |
Q1 2017 | $520,000 | +14.0% | 12,334 | +4.1% | 0.09% | -14.0% |
Q4 2016 | $456,000 | -15.7% | 11,843 | -5.7% | 0.11% | -26.2% |
Q3 2016 | $541,000 | +10.0% | 12,563 | +10.7% | 0.14% | +4.3% |
Q2 2016 | $492,000 | +32.6% | 11,350 | +24.2% | 0.14% | +4.5% |
Q1 2016 | $371,000 | -12.5% | 9,138 | -15.4% | 0.13% | -21.8% |
Q4 2015 | $424,000 | +20.5% | 10,807 | +17.9% | 0.17% | +14.1% |
Q3 2015 | $352,000 | +11.4% | 9,165 | +20.8% | 0.15% | +30.7% |
Q2 2015 | $316,000 | +150.8% | 7,590 | +157.5% | 0.11% | +107.3% |
Q4 2014 | $126,000 | +70.3% | 2,948 | +82.0% | 0.06% | +52.8% |
Q3 2014 | $74,000 | -28.2% | 1,620 | -16.0% | 0.04% | -28.0% |
Q2 2014 | $103,000 | +41.1% | 1,928 | +35.8% | 0.05% | +6.4% |
Q3 2013 | $73,000 | +25.9% | 1,420 | +23.6% | 0.05% | +9.3% |
Q2 2013 | $58,000 | – | 1,149 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |